Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Tobira Therapeutics, Inc. (TBRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/18/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 11/14/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 11/04/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 11/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2016 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Unknown transaction of 1,657 shares
@ $28.35, valued at
$47k
|
|
| 11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2016 |
4
| Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Unknown transaction of 285,679 shares
@ $28.35, valued at
$8.1M
|
|
| 11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2016 |
SC 13D/A
| Tobira Therapeutics, Inc. has filed a Schedule 13D for Tobira Therapeutics, Inc. |
| 11/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/03/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/03/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 11/03/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 11/03/2016 |
4
| Brosgart Carol L (Director) has filed a Form 4 on Tobira Therapeutics, Inc. |
| 11/03/2016 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on Tobira Therapeutics, Inc. |
| 11/03/2016 |
4
| Cooper Jeffrey H (Director) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Disposed/sold 13,539 options to buy
@ $8.13, valued at
$110.1k
Disposed/sold 15,500 options to buy
@ $16.52, valued at
$256.1k
Disposed/sold 17,778 options to buy
@ $7.91, valued at
$140.6k
|
|
| 11/03/2016 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Tobira Therapeutics, Inc.|
Txns:
| Unknown transaction of 243,726 shares
@ $0
Disposed/sold 4,332 options to buy
@ $2.96, valued at
$12.8k
Disposed/sold 15,500 options to buy
@ $16.52, valued at
$256.1k
Disposed/sold 17,778 options to buy
@ $7.91, valued at
$140.6k
|
|
| 11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2016 |
4
| Jenkins Helen (COO) has filed a Form 4 on Tobira Therapeutics, Inc. |
| 11/03/2016 |
4
| Peetz Christopher (CFO) has filed a Form 4 on Tobira Therapeutics, Inc. |
| 11/03/2016 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on Tobira Therapeutics, Inc. |
| 11/03/2016 |
4
| Fischer Laurent (CEO) has filed a Form 4 on Tobira Therapeutics, Inc. |
| 11/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/02/2016 |
SC 13D/A
| Allergan plc reports a 100% stake in Tobira Therapeutics, Inc. |
| 11/01/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 11/01/2016 |
8-K
| Quarterly results |
|
|
|